Literature DB >> 24554821

Diffuse alveolar hemorrhage following allogeneic peripheral blood stem cell transplantation: a case report and a short review.

Sanjeev Kumar Sharma1, Suman Kumar1, Avinash Kumar Singh1, Tulika Seth1, Pravas Mishra1, Sanjay Sharma2, Manoranjan Mahapatra1.   

Abstract

Pulmonary complications are one of the most common causes of morbidity and mortality in patients undergoing peripheral blood stem cell transplantation. Both infective and non-infective etiologies can involve the lungs during this period and differentiating them clinically is a challenging task and management differs in each case. We present here a case of acute myeloid leukemia, in whom following allogeneic peripheral blood stem cell transplantation, diffuse alveolar hemorrhage developed.

Entities:  

Keywords:  Allogeneic stem cell transplant; Diffuse alveolar hemorrhage; Pulmonary complications

Year:  2012        PMID: 24554821      PMCID: PMC3921334          DOI: 10.1007/s12288-012-0184-5

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  16 in total

Review 1.  Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients.

Authors:  Bekele Afessa; Ayalew Tefferi; Mark R Litzow; Michael J Krowka; Mark E Wylam; Steve G Peters
Journal:  Am J Respir Crit Care Med       Date:  2002-09-01       Impact factor: 21.405

Review 2.  Diffuse alveolar hemorrhage.

Authors:  Abigail R Lara; Marvin I Schwarz
Journal:  Chest       Date:  2010-05       Impact factor: 9.410

Review 3.  Transfusion-related acute lung injury.

Authors:  Christopher C Silliman; Nathan J D McLaughlin
Journal:  Blood Rev       Date:  2005-12-19       Impact factor: 8.250

4.  Pulmonary cytomegalovirus infection in immunocompromised patients.

Authors:  M Tamm; P Traenkle; B Grilli; M Solèr; C T Bolliger; P Dalquen; G Cathomas
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

5.  Outcome of bone marrow transplantation patients requiring mechanical ventilation.

Authors:  A J Huaringa; F J Leyva; S A Giralt; J Blanco; J Signes-Costa; H Velarde; R E Champlin
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

6.  Pulmonary infections after bone marrow transplantation: clinical and radiographic findings.

Authors:  A N Leung; M V Gosselin; C H Napper; S G Braun; W W Hu; R M Wong; J Gasman
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

7.  Pulmonary complications in adult blood and marrow transplant recipients: autopsy findings.

Authors:  Sunita Sharma; Hassan F Nadrous; Steve G Peters; Ayalew Tefferi; Mark R Litzow; Marie-Christine Aubry; Bekele Afessa
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

Review 8.  Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury.

Authors:  Ognjen Gajic; Michael A Gropper; Rolf D Hubmayr
Journal:  Crit Care Med       Date:  2006-05       Impact factor: 7.598

9.  Pneumocystis carinii pneumonitis following bone marrow transplantation.

Authors:  I Z Tuan; D Dennison; D J Weisdorf
Journal:  Bone Marrow Transplant       Date:  1992-09       Impact factor: 5.483

Review 10.  Pulmonary complications following bone marrow transplantation.

Authors:  T M Wah; H A Moss; R J H Robertson; D L Barnard
Journal:  Br J Radiol       Date:  2003-06       Impact factor: 3.039

View more
  2 in total

1.  Cost of hematopoietic stem cell transplantation in India.

Authors:  Sanjeev Kumar Sharma; Dharma Choudhary; Nitin Gupta; Mayank Dhamija; Vipin Khandelwal; Gaurav Kharya; Anil Handoo; Rasika Setia; Arpita Arora
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-07-01       Impact factor: 2.576

2.  Use of intrapulmonary administration of thrombin in hematological malignancy patients with alveolar haemorrhage: A case series.

Authors:  Jongmin Lee; Chin Kook Rhee; Seok Chan Kim; Young Kyoon Kim; Hee Je Kim; Seok Lee; Seok-Goo Cho; Jong Wook Lee
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.